Tissue expression
Cell line expression
Protein structure
NAT2
N-acetyltransferase 2AAC2
This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019]
Top validated antibodies |
|||||
antibodies-online | ABIN120937 | 12 references | Monoclonal |
WB
IP
IHC
FC
GS
|
|
Aviva Systems Biology | OAAB04117 | Polyclonal |
WB
EL
IHC
FC |
||
Invitrogen Antibodies | PA5-112621 | Polyclonal |
WB
EL
ICC
IHC |
||
Abgent | AP6993b | Polyclonal |
WB
IHC
FC
|
||
Cusabio Biotech Co., Ltd | CSB-PA015471LA01HU | Polyclonal |
WB
EL
ICC
IHC |
All Antibodies
Filters
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider